A) Disruption of cell membrane integrity B) Inhibition of DNA replication C) Inhibition of protein synthesis D) Inhibition of cell wall synthesis
A) Ribosomes B) Peptidoglycan layer of bacterial cell walls C) Cell membrane lipids D) Nucleoid region
A) Facilitate the final transpeptidation step in peptidoglycan synthesis B) Synthesize nucleic acids C) Transport nutrients across the cell membrane D) Generate energy for the cell
A) Ribosomal proteins B) DNA polymerases C) Lipoproteins D) Penicillin binding proteins (PBPs)
A) Allows them to penetrate the bacterial cell membrane B) Helps them to bind to DNA C) Enables them to inhibit ribosomal function D) Facilitates their binding to the active site of PBPs
A) Ser62 B) Lys50 C) Glu100 D) Arg75
A) Stimulation of bacterial cell division B) Enhancement of peptidoglycan synthesis C) Prevention of the final crosslinking of the peptidoglycan layer D) Activation of bacterial DNA replication
A) Viruses B) Vascular plants C) Fungi D) Bacteria, including cyanobacteria, cyanelles, and chloroplasts of bryophytes
A) Induction of cell death B) Disruption of photosynthesis C) No effect D) Inhibition of division
A) Theory of spontaneous generation B) Germ theory of disease C) Cell theory D) Endosymbiotic theory
A) High temperature B) Build-up of peptidoglycan precursors C) Presence of β-lactam antibiotics D) Absence of nutrients
A) By inhibiting bacterial DNA replication B) By increasing bacterial cell wall synthesis C) By causing the digestion of existing peptidoglycan without new production D) By promoting bacterial cell division
A) Methicillin-resistant enzyme B) Penicillinase C) β-lactamase D) Aminoglycoside acetyltransferase
A) Reverse transcriptase inhibitors B) β-lactamase inhibitors such as clavulanic acid C) Protease inhibitors D) Integrase inhibitors
A) Diarrhea B) Hyperglycemia C) Hypertension D) Bradycardia
A) Approximately 5% B) Approximately 10% C) Approximately 15% D) Approximately 2% or less
A) Approximately 10% B) Less than 1% C) Approximately 15% D) Approximately 5%
A) Serum sickness B) Anaphylactic reaction C) Jarisch–Herxheimer reaction D) Tzanck reaction
A) The solubility of the β-lactam antibiotic B) Woodward's parameter (h) C) The molecular weight of the β-lactam antibiotic D) Cohen's parameter (c)
A) The solubility of the β-lactam antibiotic B) The molecular weight of the β-lactam antibiotic C) Woodward's parameter (h) D) Cohen's parameter (c)
A) Higher h values B) Lower h values C) Constant h values D) Zero h values
A) Lower c values B) Zero c values C) Constant c values D) Higher c values
A) Thymine dimers B) 8-oxo-2'-deoxyguanosine lesions C) Single-strand breaks D) Double-strand breaks
A) A β-lactam ring B) An amide bond C) A carboxylate group D) A hydroxyl group
A) Ceftriaxone/meropenem B) Piperacillin/tazobactam C) Ceftriaxone/nitrocefin D) Amoxicillin/clavulanic acid
A) A hydroxyl group B) An amide bond C) A β-lactamase inhibitor D) An auxiliary ring with a carboxylate group
A) Meropenem B) Clavulanic acid C) Ceftriaxone D) Amoxicillin
A) It determines the antibiotic's color B) It influences the antibiotic's solubility C) It is essential for the antibiotic's antimicrobial activity D) It affects the antibiotic's taste
A) Penams B) Penems C) Carbapenams D) Oxapenams
A) β-lactam synthetase B) ACV synthetase (ACVS) C) Nonribosomal peptide synthetase D) Isopenicillin N synthase (IPNS)
A) Carbapenem B) Cephem C) Monobactam D) Isopenicillin N
A) Isopenicillin N synthase (IPNS) B) Nonribosomal peptide synthetase C) ACV synthetase (ACVS) D) β-lactam synthetase
A) Position 5 B) Position 4 C) Position 3 D) Position 1
A) Cephems B) Monobactams C) Carbapenems D) Penems
A) Penams B) Cephems C) Monobactams D) Carbapenems
A) Oxacephems B) Monobactams C) Carbacephems D) Cephems
A) Cephems B) Oxacephems C) Carbacephems D) Monobactams
A) Carbapenems B) Cephems C) Penems D) Monobactams
A) Oxacephems B) Carbacephems C) Monobactams D) Cephems
A) Oxapenams B) Penems C) Carbapenams D) Penams |